Jump to content

Heather Bresch: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m →‎MBA controversy: missing word
→‎MBA controversy: main article was renamed by consensus and is not specifically about this living person
Line 22: Line 22:
==Honors==
==Honors==
Bresch was named one of ''Fortune's'' "50 Most Powerful Women In Business" <ref>http://money.cnn.com/magazines/fortune/most-powerful-women/2012/full_list/</ref> in 2012 and 2013. In 2011, Bresch was named a ''Patriot of the Year'' by [[Esquire Magazine]] for her work which led to the passage of the FDA Safety and Innovation Act - legislation which will require foreign drugmakers that sell product in the U.S. to pay for regular facility inspections to support the FDA's efforts to continue ensuring drug safety for all U.S. consumers.<ref>[http://www.esquire.com/features/americans-2011/patriots-of-the-year-2011-1211-4#slide-4 "Esquire's Americans of the Year: Patriots"], ''Esquire Magazine'', 19 November 2011, accessed 2012-01-31</ref> Also in 2011, Bresch was named one of Pharmaceutical Executive's "Emerging Pharma Leaders 2011."<ref>http://pharmexec.findpharma.com/pharmexec/Profiles/Emerging-Pharma-Leaders-2011/ArticleStandard/Article/detail/726109?contextCategoryId=48158</ref> In 2009, Bresch was named one of the top women in the global pharmaceutical industry by FiercePharma.<ref>[http://www.fiercepharma.com/slideshows/top-15-women-pharma?img=13 "Heather Bresch - Top 15 Women in Pharma”], ''FiercePharma'' 12 Oct. 2009</ref>
Bresch was named one of ''Fortune's'' "50 Most Powerful Women In Business" <ref>http://money.cnn.com/magazines/fortune/most-powerful-women/2012/full_list/</ref> in 2012 and 2013. In 2011, Bresch was named a ''Patriot of the Year'' by [[Esquire Magazine]] for her work which led to the passage of the FDA Safety and Innovation Act - legislation which will require foreign drugmakers that sell product in the U.S. to pay for regular facility inspections to support the FDA's efforts to continue ensuring drug safety for all U.S. consumers.<ref>[http://www.esquire.com/features/americans-2011/patriots-of-the-year-2011-1211-4#slide-4 "Esquire's Americans of the Year: Patriots"], ''Esquire Magazine'', 19 November 2011, accessed 2012-01-31</ref> Also in 2011, Bresch was named one of Pharmaceutical Executive's "Emerging Pharma Leaders 2011."<ref>http://pharmexec.findpharma.com/pharmexec/Profiles/Emerging-Pharma-Leaders-2011/ArticleStandard/Article/detail/726109?contextCategoryId=48158</ref> In 2009, Bresch was named one of the top women in the global pharmaceutical industry by FiercePharma.<ref>[http://www.fiercepharma.com/slideshows/top-15-women-pharma?img=13 "Heather Bresch - Top 15 Women in Pharma”], ''FiercePharma'' 12 Oct. 2009</ref>

==MBA controversy==
{{merge|Heather Bresch M.B.A. controversy|discuss=Talk:Heather Bresch#Merge proposal|date=January 2015}}
{{main|Heather Bresch M.B.A. controversy}}
Bresch is the daughter of [[West Virginia]] U.S. Senator and former West Virginia governor [[Joe Manchin]]. She received her undergraduate degree from [[West Virginia University]].<ref name="investor.mylan.com"/> She was then an [[MBA]] student at [[West Virginia University]] until 1998. In 2007, the ''[[Pittsburgh Post-Gazette]]'' reported that Bresch said she had an MBA degree from West Virginia University. The university did have such a record, but soon after awarded her the MBA; she was missing 22 of the 48 credits in the program. After a report commissioned by the university, the university announced in April 2008 that it would rescind Bresch's degree.<ref name=postgazette>Len Boselovic and Patricia Sabatini, "[http://www.post-gazette.com/pg/08115/876164-298.stm University revokes degree after scathing report on M.B.A. awarded to Bresch]", ''Pittsburgh Post-Gazette'', 24 April 2008, accessed 2008-04-24</ref>


==References==
==References==

Revision as of 13:42, 2 February 2015

Heather Manchin Bresch
Heather Bresch testifying before the United States House Committee on Energy and Commerce in 2012.
NationalityAmerican
Alma materWest Virginia University
OccupationChief executive officer

Heather Bresch is the CEO of Mylan, Inc., a Pittsburgh-based pharmaceutical corporation.

Career

Bresch's has been Mylan's president, chief operating officer, head of North American operations and chief integration officer.[1] She joined Mylan's Board of Directors in March 2011.[2] She has been active in attempts to prevent brand-name pharmaceuticals from delaying the release of generic drugs and appeared before a special United States Senate committee on the issue in 2006[3][4] and again in 2009.[5] Bresch also testified before the Food and Drug Administration in September 2010 on the issue of generic drug user fees, proposing a new user fee structure that aims to generate more funding for the FDA and provide greater assurance for pharmaceutical product safety, regardless of where in the world the product or its ingredients come from.[6] On February 9, 2012, Bresch testified before the U.S. House of Representatives' Committee on Energy and Commerce in relation to drug supply chain integrity, drug shortages and the Generic Industry's Drug User Fee proposal (GDUFA).[7]

Honors

Bresch was named one of Fortune's "50 Most Powerful Women In Business" [8] in 2012 and 2013. In 2011, Bresch was named a Patriot of the Year by Esquire Magazine for her work which led to the passage of the FDA Safety and Innovation Act - legislation which will require foreign drugmakers that sell product in the U.S. to pay for regular facility inspections to support the FDA's efforts to continue ensuring drug safety for all U.S. consumers.[9] Also in 2011, Bresch was named one of Pharmaceutical Executive's "Emerging Pharma Leaders 2011."[10] In 2009, Bresch was named one of the top women in the global pharmaceutical industry by FiercePharma.[11]

References

Template:Persondata